AI Summary & Key Takeaways
AI InsightThe overall three year survival rate is 28%.
📌 3 Key Takeaways
Abstract
Objective: To evaluate the properties of uterine sarcoma. Material and Method: A retrospective study was done on 38 patients whose pathological results were reported as uterine sarcoma. Result: Of the 38 evaluable cases, the mean age was 47.5, leimyosarcoma was the most observed histological type, vaginal bleeding was the most pronounced symptom, stage IV patients set up the worst prognosis. 94.6% of the patients were treated by total abdominal hysterectomy and bilateral salphingo-ooferectomy, 26% of the patients were treated by postoperative chemotherapy and radıotherapy. Conclusion: The young patient group has a better prognosis.Uterine sarcoma doesn't have any spesific diagnostic sign or symptom. None of the invasive or non-invasive diagnostic procedures is enough to explain uterine sarcoma. The overall three year survival rate is 28%. Postoperative adjuvant therapy is still contraversial.
Özet
Amaç: Uterus sarkomlarının özelliklerinin belirlenmesi. Gereç ve Yöntem: Postoperatif patolojik sonucu uterus sarkomu gelen 38 hasta, retrospektif bu çalışmayla incelendi. Bulgular: Genç hastalarda prognozun daha iyi olduğu gözlendi. Uterus sarkomuna spesifik bir bulgu ve tanı yöntemi belirlenemedi, ortalama 3 yıllık sağkalım %28 olarak belirlendi. Sonuç: 38 vakada, ortalama yaş 47.5 olarak bulundu. En sık gözlenen histolojik tip leimyosarkomdu, en sık belirlenen başvuru şikayeti vajinal kanamaydı. Hastaların %94.6'sı total abdominal histerektomi ve bilateral salfingo-ooferektomi ile, tedavi olurken, postoperatif kemoterapi ve/veya radyoterapi olan hasta oranı %26 idi.